JP2011504169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011504169A5 JP2011504169A5 JP2010532496A JP2010532496A JP2011504169A5 JP 2011504169 A5 JP2011504169 A5 JP 2011504169A5 JP 2010532496 A JP2010532496 A JP 2010532496A JP 2010532496 A JP2010532496 A JP 2010532496A JP 2011504169 A5 JP2011504169 A5 JP 2011504169A5
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- solid phase
- biological material
- fragments
- phase coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims 13
- 239000011248 coating agent Substances 0.000 claims 11
- 238000000576 coating method Methods 0.000 claims 11
- 239000012620 biological material Substances 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 239000007790 solid phase Substances 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 6
- 241000203069 Archaea Species 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 4
- 210000003527 eukaryotic cell Anatomy 0.000 claims 4
- 229920001223 polyethylene glycol Polymers 0.000 claims 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 3
- 210000004369 blood Anatomy 0.000 claims 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 210000004880 lymph fluid Anatomy 0.000 claims 3
- 230000001954 sterilising effect Effects 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000005250 beta ray Effects 0.000 claims 2
- 230000027455 binding Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000005251 gamma ray Effects 0.000 claims 2
- 150000004676 glycans Chemical class 0.000 claims 2
- 239000003550 marker Substances 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 235000021317 phosphate Nutrition 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229910000077 silane Inorganic materials 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 230000002779 inactivation Effects 0.000 claims 1
- 239000002608 ionic liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000009870 specific binding Effects 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016205673A JP6898722B2 (ja) | 2007-11-07 | 2016-10-20 | 生物学的物質の固定化のための生体適合性三次元マトリクス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07021661.9 | 2007-11-07 | ||
| EP07021661.9A EP2058335B1 (en) | 2007-11-07 | 2007-11-07 | Biocompatible three dimensional matrix for the immobilization of biological substances |
| PCT/EP2008/009417 WO2009059784A1 (en) | 2007-11-07 | 2008-11-07 | Biocompatible three dimensional matrix for the immobilization of biological substances |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016205673A Division JP6898722B2 (ja) | 2007-11-07 | 2016-10-20 | 生物学的物質の固定化のための生体適合性三次元マトリクス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011504169A JP2011504169A (ja) | 2011-02-03 |
| JP2011504169A5 true JP2011504169A5 (enExample) | 2013-02-07 |
| JP6058877B2 JP6058877B2 (ja) | 2017-01-11 |
Family
ID=39026695
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532496A Expired - Fee Related JP6058877B2 (ja) | 2007-11-07 | 2008-11-07 | 生物学的物質の固定化のための生体適合性三次元マトリクス |
| JP2016205673A Expired - Fee Related JP6898722B2 (ja) | 2007-11-07 | 2016-10-20 | 生物学的物質の固定化のための生体適合性三次元マトリクス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016205673A Expired - Fee Related JP6898722B2 (ja) | 2007-11-07 | 2016-10-20 | 生物学的物質の固定化のための生体適合性三次元マトリクス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100291665A1 (enExample) |
| EP (1) | EP2058335B1 (enExample) |
| JP (2) | JP6058877B2 (enExample) |
| CN (1) | CN101910202B (enExample) |
| WO (1) | WO2009059784A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2236520A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilizing composition for immobilized biomolecules |
| JP5402721B2 (ja) * | 2010-03-01 | 2014-01-29 | 日立化成株式会社 | 検出装置及び検出方法 |
| JP6417217B2 (ja) | 2011-06-28 | 2018-10-31 | ロイコケア・アクチェンゲゼルシャフト | ウイルスまたは細菌の新規な安定化方法 |
| DE102011051692A1 (de) * | 2011-07-08 | 2013-01-10 | Peter Brehm Chirurgie-Mechanik e.K. | Verfahren zur Sterilisation von funktionalisierten, Nukleotide und/oder Nukleotidderivate enthaltenden, beschichteten Oberflächen |
| EP2902783B1 (en) * | 2012-09-28 | 2017-08-30 | Sekisui Medical Co., Ltd. | Additive for measuring diluted sample in non-dilution-type immunochromatographic method reagent |
| EP2913671A1 (en) * | 2014-02-27 | 2015-09-02 | Leukocare Ag | Novel coated carriers for the specific binding of target molecules |
| WO2016167143A1 (ja) | 2015-04-13 | 2016-10-20 | 富士フイルム株式会社 | 短鎖ペプチド固定化担体の製造方法および短鎖ペプチド固定化担体 |
| EP3205261B1 (en) | 2016-02-10 | 2018-03-28 | Nokia Technologies Oy | Intra-oral imaging |
| EP3210539B1 (en) * | 2016-02-24 | 2019-09-11 | Nokia Technologies Oy | Intra-oral x-ray detection |
| EP3282254B1 (en) * | 2016-08-12 | 2019-07-31 | IST Austria (Institute of Science and Technology Austria) | Method of producing a device for guided cell activation |
| CN109232952A (zh) * | 2018-08-07 | 2019-01-18 | 广东元星工业新材料有限公司 | 一种聚氨酯制品表面处理方法 |
| CN109187943B (zh) * | 2018-08-24 | 2021-07-30 | 四川新健康成生物股份有限公司 | 一种抗干扰试剂杯以及试剂杯内抗干扰涂层的制备方法 |
| JP6886668B2 (ja) * | 2019-04-23 | 2021-06-16 | 住友ゴム工業株式会社 | 医療用検査装置及び細胞検査方法 |
| CN110895283A (zh) * | 2019-12-10 | 2020-03-20 | 宁波奥丞生物科技有限公司 | 一种高灵敏度的d-二聚体检测试剂盒及其使用方法 |
| GB2631761A (en) * | 2023-07-13 | 2025-01-15 | Mykor Ltd | Insulation |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5426394A (en) * | 1977-07-29 | 1979-02-27 | Unitika Ltd | Method for giving enzymatic activity to solic surface |
| JPS59204601A (ja) * | 1983-05-09 | 1984-11-20 | Unitika Ltd | 生理活性を有する成形体の製造方法 |
| JPS6187700A (ja) * | 1984-10-05 | 1986-05-06 | Shimadzu Corp | ペプチド含有物質固定化物 |
| CH663728A5 (fr) * | 1985-06-10 | 1988-01-15 | Battelle Memorial Institute | Procede de purification de substances bioactives par adsorption biospecifique. |
| JPS63230088A (ja) * | 1987-03-19 | 1988-09-26 | Ngk Insulators Ltd | 微生物固定化用担体 |
| JPH01181790A (ja) * | 1988-01-18 | 1989-07-19 | Toray Silicone Co Ltd | 生理活性物質の固定化方法 |
| JPH07117519B2 (ja) * | 1988-03-19 | 1995-12-18 | 株式会社堀場製作所 | 酵素固定膜の調製方法 |
| JPH01317389A (ja) * | 1988-06-17 | 1989-12-22 | Tosoh Corp | 生化学反応用担体およびその製造方法 |
| US5077210A (en) * | 1989-01-13 | 1991-12-31 | Eigler Frances S | Immobilization of active agents on substrates with a silane and heterobifunctional crosslinking agent |
| US5283034A (en) * | 1989-06-29 | 1994-02-01 | Applied Immune Sciences, Inc. | Stabilization of sterilized surfaces for research and medical use |
| JPH0419561A (ja) * | 1990-05-14 | 1992-01-23 | Nippon Shokubai Co Ltd | 免疫アッセイ用ブロッキング剤 |
| JPH05219952A (ja) * | 1992-02-14 | 1993-08-31 | Tdk Corp | 酵素固定用担体 |
| JPH0759567A (ja) * | 1993-08-24 | 1995-03-07 | Toyobo Co Ltd | 生理活性物質固定化用担体 |
| US5674292A (en) * | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
| US5691152A (en) * | 1995-11-09 | 1997-11-25 | E. R. Squibb & Sons, Inc. | Stable avidin composition |
| US6551794B1 (en) * | 1995-11-09 | 2003-04-22 | E. R. Squibb & Sons, Inc. | Stable biotinylated biomolecule composition |
| WO1997027878A1 (en) * | 1996-02-05 | 1997-08-07 | Asahi Medical Co., Ltd. | Sterile protective agent and method for sterilization |
| US5760130A (en) * | 1997-05-13 | 1998-06-02 | Molecular Dynamics, Inc. | Aminosilane/carbodiimide coupling of DNA to glass substrate |
| JP4252123B2 (ja) * | 1998-04-23 | 2009-04-08 | ユニチカ株式会社 | 固定化線維素溶解活性酵素の活性安定化法 |
| SG93209A1 (en) * | 1999-07-05 | 2002-12-17 | Inst Of Molecular Agrobiology | A novel immuno-diagnostic test method for veterinary disease |
| AU6093300A (en) * | 1999-07-14 | 2001-02-05 | Genometrix Genomics Incorporated | Arrays comprising non-covalently associated nucleic acid probes and methods for making and using them |
| KR20000071894A (ko) * | 1999-08-19 | 2000-12-05 | 김선영 | 단백질칩 및 이를 이용한 다목적 자동화 진단시스템 |
| US20030012687A1 (en) * | 2000-03-23 | 2003-01-16 | Macphee Martin J. | Methods of sterilizing biological materials |
| AU2002216997A1 (en) * | 2000-11-17 | 2002-06-18 | Zeptosens Ag | Kit and method for multi-analyte determination with arrangements for the positionally resolved referencing of stimulating light intensity |
| US20030124199A1 (en) * | 2001-08-10 | 2003-07-03 | Karl-Heinz Nietsch | Use of fly larval extracts for wound treatment |
| US7252799B2 (en) * | 2001-08-31 | 2007-08-07 | Clearant, Inc. | Methods for sterilizing preparations containing albumin |
| US6749851B2 (en) * | 2001-08-31 | 2004-06-15 | Clearant, Inc. | Methods for sterilizing preparations of digestive enzymes |
| JP4189644B2 (ja) * | 2003-01-15 | 2008-12-03 | 東洋紡績株式会社 | 生体分子相互作用測定方法 |
| JP2005164348A (ja) * | 2003-12-02 | 2005-06-23 | Toyobo Co Ltd | 生体分子相互作用観察方法 |
| EP1571204B1 (de) * | 2004-03-04 | 2009-11-18 | LeukoCare AG | Leukozytenstimulations-Matrix |
| EP1852443A1 (en) * | 2006-05-05 | 2007-11-07 | Leukocare AG | Biocompatible three dimensional matrix for the immobilization of biological substances |
-
2007
- 2007-11-07 EP EP07021661.9A patent/EP2058335B1/en active Active
-
2008
- 2008-11-07 WO PCT/EP2008/009417 patent/WO2009059784A1/en not_active Ceased
- 2008-11-07 US US12/741,369 patent/US20100291665A1/en not_active Abandoned
- 2008-11-07 CN CN200880124134.7A patent/CN101910202B/zh not_active Expired - Fee Related
- 2008-11-07 JP JP2010532496A patent/JP6058877B2/ja not_active Expired - Fee Related
-
2016
- 2016-10-20 JP JP2016205673A patent/JP6898722B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011504169A5 (enExample) | ||
| Chakhalian et al. | Opportunities for biomaterials to address the challenges of COVID‐19 | |
| CN103443117B (zh) | 用于治疗因子在伤口环境中的结合的适体改性的聚合材料 | |
| JP2009536025A5 (enExample) | ||
| CN113151282B (zh) | 结合新型冠状病毒(SARS-CoV-2)核衣壳蛋白的核酸适配体及其用途 | |
| KR101828433B1 (ko) | 혈액으로부터 인터-알파 저해 단백질의 제조 및 조성물 | |
| Bienz et al. | Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region | |
| JP2006525796A5 (enExample) | ||
| JP2008546390A5 (enExample) | ||
| JP2006523453A5 (enExample) | ||
| CN118085109A (zh) | 免疫调节化合物 | |
| WO2013013537A1 (zh) | 一种复合胶原蛋白海绵及其制备方法 | |
| RU2008147885A (ru) | Биосовместимая трехмерная матрица для иммобилизации биологических веществ | |
| Upadhyay et al. | Recent advancement in SARS-CoV-2 diagnosis, treatment, and vaccine formulation: a new paradigm of nanotechnology in strategic combating of COVID-19 pandemic | |
| JP2021072781A (ja) | マーカー系、特にバキュロウイルス発現サブユニット抗原のためのマーカー系 | |
| JPS6098988A (ja) | Lpf−haの精製法 | |
| KR20240024064A (ko) | 코로나바이러스 및 인플루엔자 조성물 그리고 이의 사용 방법 | |
| WO2010141879A3 (en) | Peptides for transport of therapeutics and their carriers in mouse models and humans | |
| JP2011529882A5 (enExample) | ||
| JP2010509241A5 (enExample) | ||
| Bukreyev et al. | Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses | |
| US20230190242A1 (en) | Viral sample collection | |
| JP2020527102A (ja) | 抗体薬物複合体結合後の非結合薬物の除去 | |
| BRPI0412419A (pt) | proteìna de babésia, ácido nucleico, fragmento de cdna, molécula de dna recombinante, veìculo recombinante vivo, célula hospedeira, vacina, método para a preparação de uma vacina, uso de uma proteìna ou um fragmento imunogênico de referida proteìna, e, testes diagnósticos para a detecção de um ácido nucleico associado com, para a detecção de anticorpos contra, e para a detecção de material antigênico de um organismo da famìlia babesiidae | |
| JP4942034B2 (ja) | 自己抗体吸着材及び体外循環モジュール |